13‑ cis ‑retinoic acid inhibits the self‑renewal, migration, invasion and adhesion of cholangiocarci...
13‑ cis ‑retinoic acid inhibits the self‑renewal, migration, invasion and adhesion of cholangiocarcinoma cells
About this item
Full title
Author / Creator
Publisher
Athens: Spandidos Publications
Journal title
Language
English
Formats
Publication information
Publisher
Athens: Spandidos Publications
Subjects
More information
Scope and Contents
Contents
13-cis-retinoic acid (13CRA), a Food and Drug Administration-approved drug for severe acne, is currently being investigated for its potential use in skin cancer prevention. 13CRA has been reported to exhibit antitumor effects against various types of cancer cells, both in vitro and in vivo. However, to the best of our knowledge, no information is y...
Alternative Titles
Full title
13‑ cis ‑retinoic acid inhibits the self‑renewal, migration, invasion and adhesion of cholangiocarcinoma cells
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2781492191
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2781492191
Other Identifiers
ISSN
1107-3756
E-ISSN
1791-244X
DOI
10.3892/ijmm.2023.5223
